The age-related altered expression of neuron-related proteins as seen in other regions of the central nervous system is expected in the aging retina. Using immunohistochemical techniques, we characterized the distribution and aggregation of tau, AA4-amyloid, >-synuclein, and ubiquitin in human retina obtained from 19 enucleated eyes of patients aged 49 to 87 years and correlated the findings with the ages. Using a phosphorylation-independent antibody, tau aggregates were observed within the cytoplasm of several photoreceptor cells, and there was a positive correlation between age and the number of tau-positive ganglionic cells. Tau deposits were immunonegative with a phosphorylation-dependent antibody. We did not observe AA4-amyloid in subretinal pigment epithelium deposits or in neuroepithelial layers. >-Synuclein and ubiquitin inclusions were found in the inner nuclear layer, and there was colocalization of these proteins. The proportion of patients displaying such >-synuclein and/or ubiquitin intracytoplasmic inclusions was significantly higher with aging. The presence of ubiquitin deposits within drusen was remarkable, but diffuse ubiquitin aggregates between the retinal pigment epithelium and Bruch membrane were also noticed. These results indicate that protein aggregation in the retina increases with aging and that tau, >-synuclein, and ubiquitin should be the subjects of future investigations.
INTRODUCTION
Abnormal interactions between proteins that result in aberrant intracellular and extracellular deposition of selfaggregating misfolded proteins with the formation of highly ordered insoluble fibrils are common pathological hallmarks of many diverse neurodegenerative disorders. Tauopathies are characterized by distinctive intracellular inclusions, composed of insoluble, highly phosphorylated forms of tau (1) . Similarly, synucleinopathies are characterized by intracellular >-synuclein aggregates that ultimately result in the formation of Lewy bodies that contain high levels of ubiquitin (2) . Extracellular deposition of neurotoxic amyloid A-peptide AA is also widely regarded as central to the development of Alzheimer disease (3) . Aging itself involves the progressive accumulation of protein aggregates that eventually contribute to neuronal dysfunction and senescence. The ubiquitinproteasome system functions in cellular quality control by degrading misfolded, unassembled, or damaged proteins that could otherwise form potentially toxic aggregates. Either proteins can be degraded directly by the proteasome or they can be tagged with ubiquitin (4) . The presence of elevated ubiquitin conjugates associated with intracellular deposits of aggregated protein in diseased neurons in nearly all sporadic and hereditary neurodegenerative diseases has suggested a linkage between ubiquitin-proteasome system dysfunction and their pathogenesis (5, 6) . Similar pathogenic processes have been suggested in the aging or degenerating retina (7) , and a link between the accumulation of misfolded proteins and age-related retinal dystrophies has been emphasized (8) . Using immunohistochemical techniques, we aimed to characterize the distribution and aggregation of tau, AA4-amyloid, >-synuclein, and ubiquitin in human retina samples obtained from enucleated eyes. Immunohistochemical findings were correlated with the ages of the patients.
MATERIALS AND METHODS

Patient Samples
To study age-related changes in the retina, we examined 19 enucleated eyes collected during 3 consecutive years. The ages of the study patients (8 men and 11 women) ranged from 49 to 87 years (Table) . The causes for enucleation included choroid melanoma (14 cases), epidermoid carcinoma (1 case), orbital hemangioma (1 case), trauma (2 cases), and corneal abscess (1 case). Two patients (Cases 15 and 17) had a clinical presentation of Alzheimer dementia.
Neuropathology
Formalin-fixed and paraffin-embedded material was routinely examined on hematoxylin and eosinYstained sections for identification of age-related retinal lesions as follows: focal deposits (i.e. drusen) between the retinal pigment epithelium and Bruch membrane; Bhard[ drusen have discrete margins; Bsoft[ drusen[ generally have indistinct edges, are usually large, and can be confluent (9) . Damage to the retinal pigment epithelium, such as hyperpigmentation, hypopigmentation, or atrophy, and retinal atrophy were also documented.
To characterize tau aggregation, immunohistochemistry was performed on paraffin-embedded sections with a phosphorylation-independent antibody (polyclonal rabbit antihuman; Dako, Trappes, France) and with a phosphorylationdependent antibody (paired helical filament-tau monoclonal, mouse antihuman, clone AT8; Pierce Biotechnology, Rockford, IL). Immunohistochemistry was also performed with antibodies against AA4-amyloid (monoclonal mouse antihuman, clone 6F/3D; Dako), >-synuclein (monoclonal mouse antibody, clone LB509; Zymed, Montrouge, France), and ubiquitin (rabbit polyclonal antibody; Dako). The substratechromogen system was 3,3 ¶-diaminobenzidine (Dako) for tau Diffuse agg, diffuse aggregates between the retinal pigment epithelium and Bruch membrane; F, female; GC, ganglionic cells; H drusen, hard drusen; H&S, hard and soft drusen; Hyperpigm, hyperpigmented; Hypopigm, hypopigmented; INL, inner nuclear layer; M, male; PR, photoreceptors; RPE, retinal pigment epithelium; S drusen, soft drusen. and AA4-amyloid. A high-sensitivity 3-amino-9-ethylcarbazole (AEC) substrate-chromogen system (Dako) was used for >-synuclein and ubiquitin. Cells with intracytoplasmic protein aggregation were counted in 10 successive optical fields under a 60Â objective. Colocalization of >-synuclein and ubiquitin was shown by double immunofluorescence. Secondary antibodies were Alexa Fluor 488Ylabeled goat antimouse for >-synuclein and Alexa Fluor 568Ylabeled goat antirabbit (both from Invitrogen SARL, Cergy Pontoise, France) for ubiquitin.
Statistical Analyses
All data are expressed as mean T SEM. Comparisons of proportions between patient subgroups were performed using Fisher exact test. Correlations were performed using linear regressions. Statistical analyses were performed using GraphPad Prism V4.0 (San Diego, CA). For all statistical tests, a probability level of 5% (p G 0.05) was considered significant.
RESULTS
Clinicopathological data and results on the distribution of protein immunopositivity and numbers of cells with intracytoplasmic protein aggregation are summarized in the Table. Using a phosphorylation-independent antibody, we observed diffuse intracellular tau immunopositivity in the inner nuclear layer in all cases and in the ganglionic cells in 7 cases. There was a positive correlation between age and the number of tau-positive ganglionic cells (R 2 = 0.3169, p G 0.05). Moreover, tau aggregates within the cytoplasm of several photoreceptor cells were observed in 9 patients older than 63 years (Figs. 1A, B) . There was diffuse tau immunopositivity in the inner plexiform layer in all cases. No immunostaining of tau was detected using the phosphorylation-dependent antibody AT8. We did not observe AA4-amyloid immunostaining either in subretinal pigment epithelium deposits (Fig. 1C) or in neuroepithelial layers. Intracytoplasmic >-synuclein aggregates were found in the inner nuclear layer in 11 patients, coexisting with intracytoplasmic ubiquitin aggregates (Figs. 1D, E) . The colocalization of >-synuclein and ubiquitin was shown by double immunofluorescence staining (Figs. 1, FYH) . Intracytoplasmic ubiquitin aggregates were found in the inner nuclear layer in 2 other cases, whereas >-synuclein immunostaining was negative. There was extracellular ubiquitin aggregation within hard and/or soft drusen in 8 cases (Fig. 1I) . Diffuse ubiquitin aggregates between the retinal pigment epithelium and Bruch membrane were also observed in 6 cases (Fig. 1J) .
To assess the potential effect of age on the occurrence of protein aggregation in the retina, the patients were separated into 3 age groups: younger than 70 years (n = 6), between 70 and 80 years (n = 7), and older than 80 years (n = 6). The proportion of patients with >-synuclein inclusions in the inner nuclear layer was significantly higher in patients older than 80 years (5/6 cases, 83.3%) versus patients younger than 70 years (1/6 patients, 16%, p G 0.05; Fig. 2A) . Similarly, the occurrence of ubiquitin inclusions in the inner nuclear layer was affected by the patient's age (Fig. 2B) . Ubiquitin inclusions were found only in 1 of 6 patients younger than 70 years (16.6%). This proportion increased to 85.7% in patients aged 70 to 80 years (6/7 patients, p G 0.05 vs patients G70 years) and reached 100% in those older than 80 years (6/6 patients, p G 0.01 vs patients G70 years). There was a positive correlation between the number of >-synuclein inclusions and the number of ubiquitin inclusions in the inner nuclear layer (R 2 = 0.2961, p G 0.05). There was also an exponential association between age and the number of >-synuclein inclusions (R 2 = 0.2298, p G 0.05; Fig. 2C ). Because the diverse underlying eye pathologies presented by patients may have differentially affected protein metabolism and aggregation, the same analyses were performed considering only the eyes enucleated subsequently to choroid melanoma (n = 14/19 cases). The correlation between the density of >-synuclein and ubiquitin inclusions remained significant in this subsample (R 2 = 0.4246, p G 0.05). The correlation between age and the number of tau-positive ganglionic cells also remained significant (R 2 = 0.6642, p G 0.001). The proportion of cases with ubiquitin inclusions was significantly higher in patients aged 70 to 80 years (4/5 cases, 80%) and older than 80 years (3/4 cases, 75%) versus patients younger than 70 years (1/5 cases, 20%, p G 0.05). The 2 patients with a clinical presentation of Alzheimer disease (Cases 15 and 17) did not differ from those of similar ages.
DISCUSSION
An altered expression of neuron-related proteins (as seen in other CNS regions) with aging is expected in the aging or degenerating retina. Drusen, the focal deposition of acellular polymorphous debris between the retinal pigment epithelium and Bruch membrane, may be found in both the macula and peripheral retina. They are frequently found in people older than 50 years and are considered a normal part of aging (9) . However, excess drusen can lead to damage to the retinal pigment epithelium, and a chronic aberrant inflammatory response can lead to large areas of retinal atrophy. Protein misfolding and aggregation is involved in a number of retinal dystrophies (8, 10) , among which age-related macular degeneration and retinitis pigmentosa are the most common forms. Retinitis pigmentosa is a heterogeneous group of inherited disorders that cause the destruction of photoreceptor cells, the retinal pigmented epithelium, and choroid. Granular aggregates, immunoreactive for rhodopsin, form in retinitis pigmentosa; this targets rhodopsin for degradation by the ubiquitin-proteasome system (11, 12) . Abnormal accumulation of other proteins can nucleate protein aggregation and lead to the formation of deposits observed in different forms of macular degeneration (13) and other retinal diseases.
An earlier study of 24 cadaver eyes described the staining pattern of tau, amyloid precursor protein, and Aamyloid in the human retina (7) . With an anti-tau that reacts preferably with a nonphosphorylated epitope, the staining of tau was reported as intense in the inner plexiform layer and inner nuclear layer, with no change with age or retinitis pigmentosa, and with a similar but less intense staining in eyes with age-related macular degeneration. With an anti-tau antibody that reacts with a phosphatase-independent epitope, faint immunoreactivity did not change with age; however, it was slightly increased in the retinal pigment epithelium of eyes with retinitis pigmentosa and in the retina of eyes with age-related macular degeneration. Amyloid precursor protein immunoreactivity was most prominent in the ganglion cell and nerve fiber layer and seemed to increase in ganglion cells of older persons and in retinal pigment epithelium cells of eyes with retinitis pigmentosa and age-related macular degeneration. A-Amyloid immunoreactivity was only detected focally in subretinal pigment epithelium deposits in eyes from older persons.
Using a phosphorylation-independent antibody, we confirmed the presence of diffuse tau immunopositivity in the inner plexiform layer and inner nuclear layer and identified a positive correlation between age and the presence of taupositive ganglionic cells. We also observed tau aggregates within the cytoplasm of several photoreceptor cells in 9 patients older than 63 years. This pattern has not been reported previously and might be related to aging. No immunostaining of tau was detected with a phosphorylation-dependent antibody. Surprisingly, we did not observe AA4-amyloid immunopositivity either in subretinal pigment epithelium deposits or in neuroepithelial layers.
In 12 postmortem normal ocular tissues, >-synuclein was previously reported to be predominantly in the inner plexiform layer and also in individual cells located on the inner margin of the inner nuclear layer (14) . We found intracytoplasmic >-synuclein aggregates in the inner nuclear layer of 11 patients older than 68 years, indicating that >-synuclein is an aggregation-prone protein in the aging retina. As expected, intracytoplasmic ubiquitin aggregates were frequently observed in our series (present in 13 cases), coexisting and colocalized with >-synuclein aggregates in 11 cases. In addition, there was a positive correlation between the number of >-synuclein and ubiquitin inclusions in the inner nuclear layer. The proportion of patients displaying >-synuclein and/ or ubiquitin intracytoplasmic inclusions in the inner nuclear layer was significantly increased with age. An exponential association between age and the number of >-synuclein inclusions suggests an accelerated process as age increases. The presence of ubiquitin deposits within hard and/or soft drusen was remarkable, but diffuse ubiquitin aggregates between the retinal pigment epithelium and Bruch membrane were also noted. These observations suggest prominent involvement of the ubiquitin-proteasome pathway between the retinal pigment epithelium and the Bruch membrane. The ubiquitin-proteasome pathway is also involved with respect to the >-synuclein aggregates within the inner nuclear layer.
Abnormal accumulation of protein in retinal diseases may be trigged by stress or mutations, and protein aggregates are thought to act as physical barriers to intracellular transport and other essential cell functions. Targeting tau phosphorylation through inhibition of protein kinases might represent a therapeutic approach, but an important question is whether tau aggregation per se is harmful to neurons or whether it is a protective cellular response (1). Moreover, it has been suggested that oligomeric forms of tau might be instrumental in neuronal death (15) . There is a similar controversy regarding >-synuclein. Under normal physiological conditions, equilibrium is essentially shifted toward the native unfolded conformation of >-synuclein. Different triggers such as Parkinson diseaseYrelated mutations and numerous other environmental factors are able to shift this equilibrium, thus populating the partially folded conformations that are likely responsible for the death of neurons (16, 17) ; before aggregation in Lewy bodies which might have a protective role (18) .
The intracellular inclusions of denatured proteins are characteristic features of many neurodegenerative diseases, and there is a body of evidence that these various types of inclusions arise through common mechanisms. Most of these inclusions contain components of the ubiquitin-proteasome degradative pathway and also molecular chaperones, many of which are heat shock proteins. Molecular chaperones protect cells by their ability to fold, disaggregate, and refold damaged proteins or by their ability to facilitate degradation of damaged proteins. A number of molecular chaperones are expressed in the retina (8) and may be overwhelmed by the rapid rate of protein synthesis and formation of long-lived folding intermediates, thus promoting protein aggregation. Protein folding manipulations through molecular chaperones represent a challenge for future investigations that might be applicable to the treatment of retinal degenerations (10) .
